GF Fund Management’s BioAge Labs BIOA Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOA
GF Fund Management's BIOA Position: Q3 2026 in Review
GF Fund Management increased its BioAge Labs (BIOA) stake by 169% in Q3 2026, buying an estimated $21.6K and bringing the position to 2,479 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #504.
GF Fund Management first reported a position in BIOA in Q4 2025 and has held it in 4 quarters since. The position peaked at $22.6K in Q2 2026. 162 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.
- GF Fund Management held 2,479 shares of BioAge Labs worth $17.6K as of Q3 2026.
- GF Fund Management bought 1,558 BioAge Labs shares in Q3 2026, an estimated $21.6K.
- BioAge Labs made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #504 holding.
- GF Fund Management first reported a position in BioAge Labs in Q4 2025 and has held it in 4 quarters since.
- GF Fund Management's BioAge Labs position peaked at $22.6K in Q2 2026.
- 162 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.
Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.